EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review

Antonietta Gerarda Gravina iD, Raffaele Pellegrino iD, Alfonso Esposito iD, Marina Cipullo iD, Mario Romeo iD, Giovanna Palladino, Patrizia Iodice, Alessandro Federico iD, Teresa Troiani

Cancers · 31.01.2024 · 16 (3) · 611

DOI: 10.3390/cancers16030611 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 31.01.2024. Verfasst von Antonietta Gerarda Gravina und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hepatogastroenterology Division, Department of Precision Medicine, University of Campania Luigi Vanvitelli, Via L. de Crecchio, 80138 Naples, Italy. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy has emerged as a pivotal component in the treatment of various malignancies, encompassing lung, skin, gastrointestinal, and head and neck cancers. The foundation of this therapeutic approach lies in immune checkpoint inhibitors (ICI). While ICIs have demonstrated remarkable efficacy in impeding the neoplastic progression of these tumours, their use may give rise to substantial toxicity, notably in the gastrointestinal domain, where ICI colitis constitutes a significant aspect. The optimal positioning of Janus kinase (JAK)–signal transducer and activator of transcription (STAT) pathway inhibitors in the therapeutic management of ICI colitis remains unclear. Numerous reports have highlighted notable improvements in ICI colitis through the application of pan-JAK-STAT inhibitors, with tofacitinib, in particular, reporting evident clinical remission of colitis. The precise mechanism by which JAK-STAT inhibitors may impact the pathogenetic process of ICI colitis remains inadequately understood. However, there is speculation regarding their potential role in modulating memory resident CD8+ T lymphocytes. The elucidation of this mechanism requires further extensive and robust evidence, and ongoing JAK-STAT-based trials are anticipated to contribute valuable insights.

Schlagwörter

Stichwörter der Autor:innen

JAK-STATcolitisimmune checkpoint inhibitorsimmune-related adverse eventsimmunotherapytofacitinib

Autor:innen und Institutionen

  • Hepatogastroenterology Division, Department of Precision Medicine, University of Campania Luigi Vanvitelli, Via L. de Crecchio, 80138 Naples, Italy.
  • Oncology Division, Department of Precision Medicine, University of Campania Luigi Vanvitelli, Via L. de Crecchio, 80138 Naples, Italy.
  • Oncology Division, AORN Ospedali Dei Colli, Monaldi Hospital, Via L. Bianchi, 80131 Naples, Italy.

ORCID-Profile: Antonietta Gerarda Gravina, Raffaele Pellegrino, Alfonso Esposito, Marina Cipullo, Mario Romeo, Alessandro Federico

Zitieren

APA

Gravina, A. G., Pellegrino, R., Esposito, A., Cipullo, M., Romeo, M., Palladino, G., Iodice, P., Federico, A., & Troiani, T. (2024). The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review. Cancers, 16(3), 611. https://doi.org/10.3390/cancers16030611

Vancouver

Gravina AG, Pellegrino R, Esposito A, Cipullo M, Romeo M, Palladino G, et al. The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review. Cancers. 2024;16(3):611. doi:10.3390/cancers16030611

BibTeX
@article{Gravina2024,
  author = {Gravina, Antonietta Gerarda and Pellegrino, Raffaele and Esposito, Alfonso and Cipullo, Marina and Romeo, Mario and Palladino, Giovanna and Iodice, Patrizia and Federico, Alessandro and Troiani, Teresa},
  title = {The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {3},
  pages = {611},
  doi = {10.3390/cancers16030611}
}
Kostenlos starten →